State of Cell Therapy in Multiple Myeloma: Nina Shah, MD

The hematologist and oncologist from University of California, San Francisco discussed the current state of cellular therapy in multiple myeloma.

Updated KarMMA Data of Ide-Cel in Multiple Myeloma: Larry D. Anderson Jr, MD, PhD

The associate professor from the Harold C. Simmons Comprehensive Cancer Center of UT Southwestern Medical Center discussed the latest data from the KarMMA trial.

BET Proteins and T-Cell Function: Joseph A. Fraietta, PhD

The director of the Solid Tumor Immunotherapy Lab at the University of Pennsylvania discussed his research into the mechanisms of the BET protein family and T cells.